NewMed3.0

Equipe(s)
Agence de moyen
Etat
Titre du projet
Therapeutic innovation in drug discovery: A new target for the development of innovative drugs
Nom de l'appel d'offre
Agreenskills
Coordinateur.trice
Nalini Rama Rao et Gwenaëlle André-Leroux
Participants de MaIAGE
Samantha Samson, Sylvain Marthey, Gwenaëlle André-Leroux,
Partenaires (hors MaIAGE)
INRAE Ă©quipe PIMS, CEA, CNRS, UniversitĂ© TĂŒbingen Allemagne, IBR-Conicet Rosario Argentine
Année de démarrage - Année de fin de projet
2021-2024
Date de fin du projet
Résumé
Antibioresistance is a dramatic health issue and new medicines are urgently needed. A major challenge for efficient drug design is to find the appropriate bacterial target. In line with that, this project focuses on a new and innovative target. It aims at evaluating in vivo the molecular effectiveness of promising hits that we have previously identified, and to potentiate them into leads using computational and molecular structural biology.
Année de soumission
2020